ERAS

Erasca Inc

NASDAQ · Biotechnology

$12.29

+0.41 (+3.45%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

15 analysts

Buy 12 80%

Hold 2 13%

Sell 1 7%

Price Target

Analyst Price Target +100.6% upside

Low Target $19.75

Average Target $24.65

High Target $31.92

Current Price $12.29

Current
$12.29

Target
$24.65

$19.75 $24.65 avg $31.92